Opioid overdose-reversal medicine naloxone now available without prescription at CVS Pharmacies in Iowa

DES MOINES, Iowa, 2017-Mar-31 — /EPR Retail News/ — Today (March 29, 2017), CVS Health officials (NYSE: CVS) joined Iowa Lt. Gov. Kim Reynolds, Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all CVS Pharmacy locations in Iowa. CVS Health has established a standing order with physicians in Iowa that allows CVS Pharmacy to expand access to the medication in the state.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Iowa pharmacies by the use of a physician’s standing order for patients without a prescription, we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We support expanding naloxone availability to give more people a chance to get the help they need for recovery and we applaud the State of Iowa for their leadership in the fight against drug abuse and addiction.”

“Thanks to action we have taken in Iowa, first responders, family members, and others can now obtain and administer Naloxone more easily,” said Reynolds. “I want to thank CVS Health for partnering in our multi-faceted approach to combat the opioid epidemic that has affected many Iowans. We need to continue to work together to prevent, treat and respond to this epidemic.”

Today’s naloxone announcement builds on CVS Health’s longstanding commitment to helping communities address and prevent drug abuse. CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Police departments in Iowa can apply to receive a drug collection unit at www.cvs.com/safercommunities.

Additionally, CVS Health has launched digital resources on its website CVS.com that give patients and families a single destination to learn more about drug abuse prevention. And, in 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 200,000 students have already taken part in the program. High school teachers and administrators in Iowa can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

With the addition of Iowa, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 41 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

Contact:

Carolyn Castel
carolyn.castel@cvshealth.com

SOURCE: CVS Health

Opioid overdose-reversal drug naloxone now available in CVS pharmacies in Alabama, Alaska, Illinois, Missouri and West Virginia

WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now have increased access to the life-saving opioid overdose-reversal drug. CVS Health’s naloxone program establishes a standing order with a physician in the state or utilizes pharmacists’ prescriptive authority to permit CVS Pharmacists to dispense naloxone to patients without an individual prescription. Pharmacists in these five states began dispensing the medication this week.

“Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse.”

“Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic along with effective prevention, treatment, and enforcement,” said Michael Botticelli, Director of National Drug Control Policy. “Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health’s commitment to drug abuse prevention education extends from online resources launched for patients visiting CVS.com to two robust youth prevention programs. Launched last year, CVS Health’s Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to high school health classes about the dangers of drug abuse. More than 100,000 students have already been part of the program. Recently, the company also announced a partnership with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

With the addition of the five new states where CVS Pharmacy locations began dispensing naloxone to patients without a prescription this week, CVS Pharmacy locations in the following 36 states now offer naloxone: Alabama, Alaska, Arkansas,California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky,Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana,New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota,Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont,Virginia, Washington, West Virginia and Wisconsin. CVS Health also plans to further expand its naloxone program to other states in the coming months.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health and Adapt Pharma to make opioid overdose-reversing drug NARCAN Nasal Spray affordable for patients without insurance at CVS Pharmacies

WOONSOCKET, R.I., 2016-Aug-02 — /EPR Retail News/ — CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication, reducing the out-of-pocket cost by nearly 25 percent. NARCAN Nasal Spray is the first and only FDA-approved, ready-to-use nasal formulation of naloxone for the emergency treatment of opioid overdose. NARCAN Nasal Spray is available in a convenient box containing two units (each unit delivers a concentrated 4mg dose of active medication-naloxone hydrochloride- in a .1ml mist) for immediate use if the need arises.

“Having a ready-to-use dose of naloxone in a nasal spray device makes administration of this life-saving medication quick and easy for friends and families of loved ones struggling with addiction in an emergency overdose situation,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Health. “Through this partnership with Adapt Pharma, NARCAN Nasal Spray will be more affordable for CVS Pharmacy patients who don’t have insurance. CVS Health is dedicated to helping communities address and prevent prescription drug abuse, which is why we have worked to increase access to the opioid overdose-reversal drug naloxone for patients. Using a physician’s standing order or collaborative practice agreement, we have eliminated the need for patients to obtain a prescription for naloxone in 31 states across the country.”

“This partnership is an important milestone in increasing access to FDA-approved naloxone formulations across U.S. communities. We are encouraged by the progress marked by CVS Pharmacy’s decision to improve affordability of NARCAN Nasal Spray, especially within states with standing orders, which allow patient access to this opioid overdose treatment without physician-written naloxone prescriptions,” saidSeamus Mulligan, Chairman and CEO of Adapt Pharma. “NARCAN Nasal Spray was designed with communities in mind, specifically breaking down barriers to a medication that has been proven, intuitive and ready-to-use by those most likely to encounter an overdose emergency, the friends, loved ones and caregivers of patients susceptible to opioid-related overdose. Now these community members will be able to access the first and only FDA-approved, ready-to-use nasal spray version of naloxone in thousands of CVS Pharmacy locations nationwide.”

CVS Health’s naloxone program establishes a standing order with a physician, which permits CVS Pharmacists to dispense naloxone to patients without an individual prescription. By August 2016, CVS Health will make this life-saving medication more accessible to CVS Pharmacy patients in 31 states: Arkansas, California, Colorado,Florida, Idaho, Indiana, Louisiana, Massachusetts, Minnesota, Mississippi, Montana,New Jersey, New York, North Dakota, Oregon, Pennsylvania, Rhode Island,Tennessee, Texas, Utah, Washington, Wisconsin, Connecticut, Kentucky, Maryland,North Carolina, New Hampshire, New Mexico, Ohio, Virginia and Vermont.

CVS Health’s commitment to help communities address and prevent drug abuse also includes drug abuse prevention education, outreach and access to safe medication disposal. Patients visiting CVS.com can find recently launched drug abuse prevention resources for themselves and their families. The company has also launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 100,000 students have already been part of the program.

CVS Health has also joined with the Partnership for Drug-Free Kids for the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 43 metric tons of prescription drugs. Members of the community can use a zip code locator at CVS.com to find the disposal unit closest to them.

About CVS Health
CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Adapt Pharma
Adapt Pharma is a privately-held pharmaceutical company committed to positively impacting the lives of patients. Adapt Pharma’s strategy is to identify, evaluate, selectively acquire and enhance the value of late stage development, and FDA approved, pharmaceutical products. Adapt Pharma’s company headquarters is in Dublin, Ireland and its U.S. headquarters is in Radnor, Pennsylvania. For more information, please visit www.adaptpharma.com.

Media Contact:

Carolyn Castel
Corporate Communications
(401) 770-5717
Carolyn.Castel@CVSHealth.com

Adapt Pharma Media Contact:

Thom Duddy
Executive Director, Communications & Marketing
(484) 532-5470
Thomas.Duddy@adaptpharma.com

SOURCE: CVS Health